Adolescents with non-segmental vitiligo who applied topical ruxolitinib, 1.5% cream were more likely than adults to achieve ...

More than four years after the pandemic began, childhood vaccination rates worldwide have yet to recover, a new report shows.

In a new poll, most respondents said their biggest health concern is getting diagnosed with cancer when it's too late to ...

As you can see below, at the end of March 2024, Pfizer had US$69.9b of debt, up from US$36.2b a year ago. Click the image for more detail. However, it does have US$11.9b in cash offsetting this, ...

Pfizer (PFE) stock has been struggling, but looking among the market’s laggards can yield attractive opportunities. The stock ...

Notably, Goldman Sachs reaffirmed its "Buy" rating after earnings with a price target of $31, citing strong performance from products like Padcev and Vindaqel. BMO Capital also reiterated its ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on KalVista Pharmaceuticals (KALV – Research ...

Companies including Eli Lilly, BMS, Pfizer, AbbVie, Novartis and GSK increased prices of certain drugs by an average of 7%.

According to a recently released industry report by Fact.MR, the global Uveitis Treatment Market is poised to be valued at US$ 791 million ...

The energy sector, encompassing oil, gas and renewable energy, is another major player in wealth creation. Companies like ...

Mitchell resides in Alliance with his wife, Jaclyn, and their three children. He serves on the board of a local child ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.